EUVIMEDEUVIMED entdecken
Open Access

Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma

Alexander M Xu iD, Marcela Haro, Ann E Walts iD, Ye Hu, Joshi John, Beth Y Karlan iD, Akil Merchant iD, Sandra Orsulic iD

Science Advances · 19.04.2024 · 10 (16)

DOI: 10.1126/sciadv.adk8805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 19.04.2024. Verfasst von Alexander M Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Antineoplastic Agents, Ovarian Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-grade serous ovarian carcinoma (HGSOC), the deadliest form of ovarian cancer, is typically diagnosed after it has metastasized and often relapses after standard-of-care platinum-based chemotherapy, likely due to advanced tumor stage, heterogeneity, and immune evasion and tumor-promoting signaling from the tumor microenvironment. To understand how spatial heterogeneity contributes to HGSOC progression and early relapse, we profiled an HGSOC tissue microarray of patient-matched longitudinal samples from 42 patients. We found spatial patterns associated with early relapse, including changes in T cell localization, malformed tertiary lymphoid structure (TLS)–like aggregates, and increased podoplanin-positive cancer-associated fibroblasts (CAFs). Using spatial features to compartmentalize the tissue, we found that plasma cells distribute in two different compartments associated with TLS-like aggregates and CAFs, and these distinct microenvironments may account for the conflicting reports about the role of plasma cells in HGSOC prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsAntineoplastic AgentsOvarian NeoplasmsFemaleHumansNeoplasm Recurrence, LocalRecurrenceTumor Microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Division of Hematology and Cellular Therapy, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Obstetrics and Gynecology and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Department of Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

ORCID-Profile: Alexander M Xu, Ann E Walts, Beth Y Karlan, Akil Merchant, Sandra Orsulic

Förderung

  • BLRD VA
  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Xu, A. M., Haro, M., Walts, A. E., Hu, Y., John, J., Karlan, B. Y., Merchant, A., & Orsulic, S. (2024). Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Science Advances, 10(16). https://doi.org/10.1126/sciadv.adk8805

Vancouver

Xu AM, Haro M, Walts AE, Hu Y, John J, Karlan BY, et al. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Science Advances. 2024;10(16). doi:10.1126/sciadv.adk8805

BibTeX
@article{Xu2024,
  author = {Xu, Alexander M and Haro, Marcela and Walts, Ann E and Hu, Ye and John, Joshi and Karlan, Beth Y and Merchant, Akil and Orsulic, Sandra},
  title = {Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {16},
  doi = {10.1126/sciadv.adk8805}
}
Kostenlos starten →